D.E. Shaw & Co
CMLFU

D.E. Shaw & Co’s CM Life Sciences, Inc. Unit CMLFU Stock Holding History

D.E. Shaw & Co’s Portfolio CMLFU Stock Details CMLFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,495,000
Closed -$17.3M – 4658
2020
Q4 		$17.3M Hold
1,495,000
– – 0.02% 1034
2020
Q3 		$15.7M Buy
+1,495,000
New +$15.7M 0.02% 967

Other funds holding CMLFU

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCP
Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
ACM
Arrow Capital Management New York $144M AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

D.E. Shaw & Co's CMLFU Position: Q1 2021 in Review

D.E. Shaw & Co sold out of CM Life Sciences, Inc. Unit (CMLFU) in Q1 2021, closing a stake of 1,495,000 shares — an estimated $17.3M sold.

D.E. Shaw & Co first reported a position in CMLFU in Q3 2020 and held it in 2 quarters. The position peaked at $17.3M in Q4 2020. 21 funds tracked by Wall St. Rank hold CMLFU as of Q1 2021.

  • D.E. Shaw & Co reported no remaining CM Life Sciences, Inc. Unit position as of Q1 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,495,000 CM Life Sciences, Inc. Unit shares in Q1 2021, an estimated $17.3M.
  • D.E. Shaw & Co first reported a position in CM Life Sciences, Inc. Unit in Q3 2020 and held it in 2 quarters.
  • D.E. Shaw & Co's CM Life Sciences, Inc. Unit position peaked at $17.3M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held CM Life Sciences, Inc. Unit as of Q1 2021.

Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.